Understanding the features of Restless Legs Syndrome.
Clinical Features Associated With Restless Legs Syndrome : Clin-RLS
This study looks at how different factors like symptoms, other health conditions, and medications affect people with Restless Legs Syndrome over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT05044520 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the evolution of symptoms in patients with Restless Legs Syndrome (RLS) by examining clinical, biological, and pharmacological factors. It will involve a large cohort of RLS patients who are members of the French RLS association and other European RLS associations. The study will focus on how RLS phenotype, comorbidities, and medications influence the severity of symptoms over time. By gathering data from this population, the study seeks to provide insights into the natural course of RLS and its complications.
Who should consider this trial
Good fit: Ideal candidates for this study are French-speaking adults diagnosed with Restless Legs Syndrome who are members of the RLS association.
Not a fit: Patients who are not members of the RLS association or those who are legally protected or deprived of liberty may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of Restless Legs Syndrome, enhancing patient quality of life.
How similar studies have performed: While there have been few studies on RLS, this study's comprehensive approach to understanding symptom evolution is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Adults subjects * Restless legs syndrome diagnosis * Member of the restless legs syndrome association * French speaking * Able to understand the study * Signed written informed consent * Affiliated to social security Exclusion criteria: \- Vulnerable subject : subject deprived of liberty or protected by law (trusteeship, legal guardianship)
Where this trial is running
Montpellier
- Uhmontpellier — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: Sofiene Chenini, MD
- Email: sofienechenini@hotmail.com
- Phone: 467332237
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.